000720837 000__ 04316cam\a2200481\i\4500
000720837 001__ 720837
000720837 005__ 20210515103336.0
000720837 006__ m\\\\\o\\d\\\\\\\\
000720837 007__ cr\cn\nnnunnun
000720837 008__ 130212t20122012dcu\\\\\ob\\\\100\0\eng\d
000720837 020__ $$z9780309261166$$qpaperback
000720837 020__ $$z0309261163$$qpaperback
000720837 020__ $$a9780309261173$$qelectronic book
000720837 035__ $$a(CaPaEBR)ebr10863714
000720837 040__ $$aCaPaEBR$$beng$$erda$$epn$$cCaPaEBR
000720837 05014 $$aRM302$$b.I58 2012eb
000720837 08204 $$a615.1/9$$223
000720837 1102_ $$aInstitute of Medicine (U.S.).$$bForum on Drug Discovery, Development, and Translation,$$eissuing body.
000720837 24510 $$aMaximizing the impact of the Cures Acceleration Network$$h[electronic resource] :$$baccelerating the development of new drugs and diagnostics : workshop summary /$$cSteve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
000720837 24630 $$aAccelerating the development of new drugs and diagnostics
000720837 264_1 $$aWashington, District of Columbia :$$bNational Academies Press,$$c[2012]
000720837 264_4 $$c©2012
000720837 300__ $$a1 online resource (131 pages)
000720837 336__ $$atext$$2rdacontent
000720837 337__ $$acomputer$$2rdamedia
000720837 338__ $$aonline resource$$2rdacarrier
000720837 504__ $$aIncludes bibliographical references (pages 71).
000720837 5050_ $$aIntroduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN.
000720837 506__ $$aAccess limited to authorized users.
000720837 520__ $$aAdvances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite these opportunities, only a small fraction of investigational products are successfully developed into cures and therapies that can be accessed by patients. One response to the ever-widening gap between the number and promise of basic scientific discoveries and the translation of those discoveries into therapies is a renewed emphasis on collaborative approaches among federal agencies, academia, and industry, all directed at the advancement of the drug development enterprise. The newly developed Cures Acceleration Network (CAN)-a part of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH)-has the potential to catalyze widespread changes in NCATS, NIH, and the drug development ecosystem in general. On June 4-5, 2012, the IOM Forum on Drug Discovery, Development, and Translation held, at the request of NCATS, a workshop-bringing together members of federal government agencies, the private sector, academia, and advocacy groups-to explore options and opportunities in the implementation of CAN. Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary summarizes the workshop."--Publisher's description.
000720837 588__ $$aDescription based on print version record.
000720837 61010 $$aUnited States.$$bInstitutes of Health.$$bNational Center for Advancing Translational Sciences.$$bCures Acceleration Network.
000720837 650_0 $$aDrug monitoring.
000720837 650_0 $$aDrug development$$zUnited States.
000720837 650_0 $$aDrugs$$zUnited States$$xDesign.
000720837 650_0 $$aPharmaceutical industry$$zUnited States$$xQuality control.
000720837 7001_ $$aOlson, Steve,$$d1956-$$econtributor.
000720837 7001_ $$aClaiborne, Anne B.,$$econtributor.
000720837 7102_ $$aNational Institute of Medicine (U.S.).$$bBoard on Health Sciences Policy,$$eissuing body.
000720837 77608 $$iPrint version:$$aInstitute of Medicine (U.S.).$$tMaximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary.$$dWashington, District of Columbia : National Academies Press, [2012]$$z9780309261166$$w(OCoLC)ocn811963294
000720837 852__ $$bebk
000720837 85640 $$3ProQuest Ebook Central Academic Complete$$uhttps://univsouthin.idm.oclc.org/login?url=http://site.ebrary.com/lib/usiricelib/Doc?id=10863714$$zOnline Access
000720837 909CO $$ooai:library.usi.edu:720837$$pGLOBAL_SET
000720837 980__ $$aEBOOK
000720837 980__ $$aBIB
000720837 982__ $$aEbook
000720837 983__ $$aOnline